List All Head and Neck Cancer Trials

Head and Neck Cancer

 

Postoperative Radiation Therapy +/- Cetuximab for Head and Neck Cancer (RTOG 0920)
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally - Advanced Resected Head and Neck Cancer

Investigator: George Laramore, MD, PhD;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01311063

Recombinant Interleukin-15 in Treating Patients With Advanced Solid Tumors
A Phase 1 Study of Recombinant Human IL15 (rhIL15) in Adults With Advanced Solid Tumors: Melanoma, Renal Cell, Non-Small Cell Lung and Head and Neck Cancer

Investigator: John A. Thompson, MD;   Conditions: Melanoma, Kidney Cancer, Non-Small Cell Lung Cancer, Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01727076

Radiation Therapy w w/o Cetuximab Post Surgery for Locally Advanced Head and Neck Cancer (RTOG 0920)
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer

Investigator: George E. Laramore, MD, PhD;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT00956007

Transoral Surgery Followed By Low/Standard-Dose Radiation Therapy w w/o Chemotherapy for HPV Positive Oropharyngeal Cancer (ECOG-ACRIN E3311)
Phase II Randomized Trial of Transoral Surgical Resection Followed by Low-Dose or Standard-Dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Investigator: Eduardo Mendez, MD;   Conditions: Stage III,IVA, IVB Squamous Cell Carcinoma of the Oropharynx;    Status: Pending;   Study ID: NCT01898494

Transoral Surgery Plus Radiation for HPV Positive Stage III-IVA Oropharyngeal Cancer(9188)
Phase II Randomized Trial of Transoral Surgical Resection followed by Low-dose or Standard-dose IMRT in Resectable p16+ Locally Advanced Oropharynx Cancer

Investigator: Eddie Mendez;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT01898494

AZD1775, Docetaxel, and Cisplatin Pre-Surgery in Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck (9168)
A Phase I Clinical Trial of AZD1775 in Combination With Neoadjuvant Weekly Docetaxel and Cisplatin Prior to Surgery in Squamous Cell Carcinoma of the Head and Neck (HNSCC)

Investigator: Eduardo Mendez;   Conditions: Stage III-IVB Squamous Cell Carcinoma;    Status: Recruiting;   Study ID: NCT02508246

Pembrolizumab for Recurrent or Metastatic Head and Neck Cancer (20150009)
A Phase III Randomized Trial of MK-3475 (Pembrolizumab) versus Standard Treatment in Subjects with Recurrent or Metastatic Head and Neck Cancer

Investigator: Cristina Rodriguez, MD;   Conditions: Head and Neck Cancer, Squamous Cell;    Status: Recruiting;   Study ID: NCT02252042

MK-3475 Combined with Vorinostat for Metastatic Squamous Cell Head and Neck Cancer (9383)
A single arm Phase I/II study of MK-3475 combined with vorinostat for recurrent unresectable and/or metastatic squamous cell head and neck cancer and recurrent unresectable and/or metastatic salivary gland malignancies

Investigator: Cristina Rodriguez, MD;   Conditions: Head and Neck Cancer;    Status: Recruiting;   Study ID: NCT02538510